From professional translators, enterprises, web pages and freely available translation repositories.
terminalinis radioaktyvumo pusperiodis yra apie 130 val.
the terminal half-life for radioactivity was about 130 hours indicating that elimination of metabolites is very slow.
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
terminalinis pusinės eliminacijos periodas yra apie vieną parą.
following intravenous administration, follitropin alfa is distributed to the extracellular fluid space with an initial half-life of around 2 hours and eliminated from the body with a terminal half-life of about one day.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
nt-prosnp – smegenų natriuretinio peptido n-terminalinis prohormonas
nt-probnp =n-terminal prohormone of brain natriuretic peptide
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
pacientai, kuriems yra terminalinis inkstų pakenkimas ir kuriems reikia dializės.
end stage renal disease patients requiring dialysis.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
bendras dasatinibo vidutinis terminalinis pusinis laikas pacientų organizme yra maždaug 5- 6 val.
17 approximately proportional to the dose increment across doses ranging from 25 mg to 120 mg twice daily.
Last Update: 2011-10-23
Usage Frequency: 4
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
vidutinis terminalinis pusins eliminacijos periodas suleidus sias dozes svyravo nuo 8 iki 9, 5 dienos.
the median terminal half-life at these doses ranged from 8 to 9.5 days.
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
6 eliminacija 5-ala eliminacija yra greita, terminalinis pusins eliminacijos laikas yra 1-3 valandos.
elimination 5-ala is eliminated quickly with a terminal half-life of 1-3 hours.
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
terminalinis inkstų funkcijos nepakankamumas (esrd) (klkr < 30 ml/ min, reikalinga dializė)
end stage renal disease (esrd) (clcr < 30 ml/min, requiring dialysis)
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
Warning: Contains invisible HTML formatting
eliminacija suminis rosiglitazono klirensas plazmoje mazdaug 3 l/val., jo terminalinis eliminacijos pusperiodis mazdaug 3-4 val.
elimination total plasma clearance of rosiglitazone is around 3 l/h and the terminal elimination half-life of rosiglitazone is approximately 3 to 4 hours.
Last Update: 2008-03-04
Usage Frequency: 3
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
suminis roziglitazono klirensas plazmoje – maždaug 3 l/val., jo terminalinis eliminacijos pusperiodis – maždaug 3-4 val.
total plasma clearance of rosiglitazone is around 3 l/h and the terminal elimination half-life of rosiglitazone is approximately 3 to 4 hours.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
eliminacija suminis roziglitazono klirensas plazmoje – maždaug 3 l/ val., jo terminalinis eliminacijos pusperiodis – maždaug 3- 4 val.
elimination total plasma clearance of rosiglitazone is around 3 l/ h and the terminal elimination half-life of rosiglitazone is approximately 3 to 4 hours.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
vartojant 10 mg/kg, vidutinis terminalinis pusinis laikas buvo 13, 1 dienos (diapazonas -8-25 dien) .
at 10 mg/kg, the mean terminal half-life was 13.1 days, ranging from 8 to 25 days.
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
vartojant 10 mg/kg, vidutinis terminalinis pusinis laikas buvo 13,1 dienos (diapazonas - 8-25 dienos).
at 10 mg/kg, the mean terminal half-life was 13.1 days, ranging from 8 to 25 days.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
testosterono koncentracija daznai yra mazesn uz norm pacientams, kuriems yra terminalin inkst ligos stadija.
testosterone levels are often below the normal range in patients with end-stage renal disease.
Last Update: 2008-03-04
Usage Frequency: 6
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.